+987.9%
MRNA vs NVDX
-27.2%
+1,015.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVDX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -6.2% | +19.3% | +13.4% |
| 7D | +20.6% | -14.1% | +34.7% | +21.4% |
| 30D | +27.1% | -31.3% | +58.5% | +28.9% |
| 3M | +353.4% | -16.2% | +369.5% | +356.2% |
| 6M | +446.3% | -11.9% | +458.1% | +443.4% |
| YTD | +776.2% | -9.4% | +785.6% | +745.7% |
| 1Y | +987.9% | -23.9% | +1,011.8% | +924.8% |
| All | +987.9% | -27.2% | +1,015.1% | +924.8% |
Cumulative growth
Daily Returns
Daily percentage return beside NVDX.
Daily Out/Under-Performance
Portfolio return minus NVDX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVDX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVDX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling